ASCO 2019 Cleveland researchers test novel gene therapy for glioblastoma

ASCO 2019: Cleveland researchers test novel gene therapy for glioblastoma

07:49 EDT 4 Jun 2019 | ecancermedicalscience

A novel gene therapy clinical trial at University Hospitals Seidman Cancer Center and the Case Comprehensive Cancer Center is showing promising results, garnering funding with a prestigious U01 Grant from the National Cancer Institute. The trial focuses...

More From BioPortfolio on "ASCO 2019: Cleveland researchers test novel gene therapy for glioblastoma"